1. Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results. (28th September 2017) Authors: Aparicio, T; Bouché, O; Taieb, J; Maillard, E; Kirscher, S; Etienne, P -L; Faroux, R; Khemissa Akouz, F; El Hajbi, F; Locher, C; Rinaldi, Y; Lecomte, T; Lavau-Denes, S; Baconnier, M; Oden-Gangloff, A; Genet, D; Paillaud, E; Retornaz, F; François, E; Bedenne, L Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-080Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REGIRI). (2nd July 2019) Authors: Samalin, E; Turpin, A; Khemissa, F; Zaanan, A; Benabdelghani, M; Senellart, H; Gilabert, M; Evesque, L; Dahan, L; Sefrioui, D; Bouché, O; De la Fouchardière, C; Hennequin, A; Monard, L; Gourgou, S; Lopez, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗